Impact of graphene oxide on the structure and function of important multiple blood components by a dose-dependent pattern

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 6, 2015, Pages 2006-2014

  Feng, Ru ^a   Yu, Yueping ^a   Shen, Chaoxuan ^a   Jiao, Yanpeng ^a   Zhou, Changren ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

blood clotting; complement activation; graphene oxide; plasma proteins; red blood cells

Indexed keywords

BODY FLUIDS; CELLS; CHEMICAL ACTIVATION; COAGULATION; CONFORMATIONS; DICHROISM; GRAPHENE; MEDICAL APPLICATIONS; MORPHOLOGY; SCANNING ELECTRON MICROSCOPY;

BLOOD CLOTTING; COMPLEMENT ACTIVATIONS; GRAPHENE OXIDES; PLASMA PROTEIN; RED BLOOD CELL;

BLOOD;

BOVINE SERUM ALBUMIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; FIBRINOGEN; GRAPHENE OXIDE; GRAPHITE; OXIDE;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD COMPONENT; CHEMICAL INTERACTION; CIRCULAR DICHROISM; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE MEMBRANE; FLUORESCENCE SPECTROSCOPY; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; MORPHOLOGY; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTHROMBIN TIME; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE POOR PLASMA; THROMBOELASTOGRAPHY; ANIMAL; BOVINE; CYTOLOGY; DRUG EFFECTS; KINETICS; METABOLISM; SPECTROFLUOROMETRY; TEMPERATURE; ULTRASTRUCTURE;

ANIMALS; BLOOD COAGULATION; CATTLE; CIRCULAR DICHROISM; COMPLEMENT ACTIVATION; ERYTHROCYTES; FIBRINOGEN; GRAPHITE; HEMOLYSIS; HUMANS; KINETICS; OXIDES; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PROTHROMBIN TIME; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE; TEMPERATURE; THROMBELASTOGRAPHY;

EID: 84928583414     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35341     Document Type: Article

References (53)

1. Krug HF, Wick P,. Nanotoxicology: An interdisciplinary challenge. Angew Chem Int Ed 2011; 50: 1260-1278.
2. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B,. Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011; 1810: 361-373.
3. Naeye B, Deschout H, Röding M, Rudemo M, Delanghe J, Devreese K, Demeester J, Braeckmans K, De Smedt SC, Raemdonck K,. Hemocompatibility of siRNA loaded dextran nanogels. Biomaterials 2011; 32: 9120-9127.
4. Ilinskaya AN, Dobrovolskaia MA,. Nanoparticles and the blood coagulation system. Part II: Safety concerns. Nanomedicine 2013; 8: 1013-1026.
5. Zhu Y, Murali S, Cai W, Li X, Suk JW, Potts JR, Ruoff RS,. Graphene and graphene oxide: Synthesis, properties, and applications. Adv Mater 2010; 22: 3906-3924.
6. Emtsev KV, Bostwick A, Horn K, Jobst J, Kellogg GL, Ley L, McChesney JL, Ohta T, Reshanov SA, Röhrl J,. Towards wafer-size graphene layers by atmospheric pressure graphitization of silicon carbide. Nat Mater 2009; 8: 203-207.
7. Bitounis D, Ali-Boucetta H, Hong BH, Min DH, Kostarelos K,. Prospects and challenges of graphene in biomedical applications. Adv Mater 2013; 25: 2258-2268.
8. Dobrovolskaia MA, Germolec DR, Weaver JL,. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 2009; 4: 411-414.
9. Simpfendorfer C, Kottke-Marchant K, Lowrie M, Anders RJ, Burns DM, Miller DP, Cove CS, DeFranco AC, Ellis SG, Moliterno DJ,. First chronic platelet glycoprotein iib/iiia integrin blockade a randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions. Circulation 1997; 96: 76-81.
10. Bao H, Pan Y, Ping Y, Sahoo NG, Wu T, Li L, Li J, Gan LH,. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 2011; 7: 1569-1578.
11. Tripathi SK, Goyal R, Gupta KC, Kumar P,. Functionalized graphene oxide mediated nucleic acid delivery. Carbon 2013; 51: 224-235.
12. Wang Y, Li Z, Hu D, Lin CT, Li J, Lin Y,. Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. J Am Chem Soc 2010; 132: 9274-9276.
13. Feng L, Chen Y, Ren J, Qu X,. A graphene functionalized electrochemical aptasensor for selective label-free detection of cancer cells. Biomaterials 2011; 32: 2930-2937.
14. Liu X, Aizen R, Freeman R, Yehezkeli O, Willner I,. Multiplexed aptasensors and amplified DNA sensors using functionalized graphene oxide: Application for logic gate operations. Acs Nano 2012; 6: 3553-3563.
15. Zhang L, Xia J, Zhao Q, Liu L, Zhang Z,. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010; 6: 537-544.
16. Lee WC, Lim CHY, Shi H, Tang LA, Wang Y, Lim CT, Loh KP,. Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. ACS nano 2011; 5: 7334-7341.
17. Chen GY, Pang DP, Hwang SM, Tuan HY, Hu YC,. A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials 2012; 33: 418-427.
18. Liu S, Zeng TH, Hofmann M, Burcombe E, Wei J, Jiang R, Kong J, Chen Y,. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: Membrane and oxidative stress. Acs Nano 2011; 5: 6971-6980.
19. Zhao J, Deng B, Lv M, Li J, Zhang Y, Jiang H, Peng C, Li J, Shi J, Huang Q, Fan C,. Graphene oxide-based antibacterial cotton fabrics. Adv Healthc Mater 2013; 2: 1259-1266.
20. Santos CM, Tria MC, Vergara RA, Ahmed F, Advincula RC, Rodrigues DF,. Antimicrobial graphene polymer (PVK-GO) nanocomposite films. Chem Commun 2011; 47: 8892-8894.
21. Gurunathan S, Han JW, Eppakayala V, Dayem AA, Kwon DN, Kim JH,. Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells. Nanoscale Res Lett 2013; 8: 393.
22. Akhavan O, Ghaderi E, Emamy H,. Nontoxic concentrations of PEGylated graphene nanoribbons for selective cancer cell imaging and photothermal therapy. J Mater Chem 2012; 22: 20626-20633.
23. Gollavelli G, Ling YC,. Multi-functional graphene as an in vitro and in vivo imaging probe. Biomaterials 2012; 33: 2532-2545.
24. Zhang W, Wang C, Li Z, Lu Z, Li Y, Yin JJ, Zhou YT, Gao X, Fang Y, Nie G,. Unraveling stress-induced toxicity properties of graphene oxide and the underlying mechanism. Adv Mater 2012; 24: 5391-5397.
25. Hu W, Peng C, Lv M, Li X, Zhang Y, Chen N, Fan C, Huang Q,. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. Acs Nano 2011; 5: 3693-3700.
26. Akhavan O, Ghaderi E, Emamy H, Akhavan F,. Genotoxicity of graphene nanoribbons in human mesenchymal stem cells. Carbon 2013; 54: 419-431.
27. Akhavan O, Hashemi E, Shamsara M, Rahighi R, Esfandiar A, Tayefeh AR,. Cyto-and geno-toxicities of graphene oxide and reduced graphene oxide sheets on spermatozoa. RSC Adv 2014; 4: 27213-27223.
28. Liao KH, Lin YS, Macosko CW, Haynes CL,. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces 2011; 3: 2607-2615.
29. Tan X, Feng L, Zhang J, Yang K, Zhang S, Liu Z, Peng R,. Functionalization of graphene oxide generates a unique interface for selective serum protein interactions. ACS Appl Mater Interfaces 2013; 5: 1370-1377.
30. Sasidharan A, Panchakarla LS, Sadanandan AR, Ashokan A, Chandran P, Girish CM, Menon D, Nair SV, Rao C, Koyakutty M,. Hemocompatibility and macrophage response of pristine and functionalized graphene. Small 2012; 8: 1251-1263.
31. Zhang S, Yang K, Feng L, Liu Z,. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon 2011; 49: 4040-4049.
32. Liu Z, Jiao Y, Wang T, Zhang Y, Xue W,. Interactions between solubilized polymer molecules and blood components. J Control Release 2012; 160: 14-24.
33. Trynda-Lemiesz L, Karaczyn A, Keppler BK, Kozlowski H,. Studies on the interactions between human serum albumin and trans-indazolium (bisindazole) tetrachlororuthenate (III). J Inorg Biochem 2000; 78: 341-346.
34. Zhou X, Yang Q, Xie X, Hu Q, Qi F, Rahman ZU, Chen X,. NMR, multi-spectroscopic and molecular modeling approach to investigate the complexes between CI Acid Orange 7 and human serum albumin in vitro. Dyes Pigments 2012; 92: 1100-1107.
35. Zhong D, Jiao Y, Zhang Y, Zhang W, Li N, Zuo Q, Wang Q, Xue W, Liu Z,. Effects of the gene carrier polyethyleneimines on structure and function of blood components. Biomaterials 2013; 34: 294-305.
36. Farrugia A,. Albumin usage in clinical medicine: Tradition or therapeutic? Transfus Med Rev 2010; 24: 53-63.
37. He XM, Carter DC,. Atomic structure and chemistry of human serum albumin. Nature 1992; 358: 209-215.
38. Mandeville J, Tajmir-Riahi H,. Complexes of dendrimers with bovine serum albumin. Biomacromolecules 2010; 11: 465-472.
39. Park SJ, Khang D,. Conformational changes of fibrinogen in dispersed carbon nanotubes. Int J Nanomed 2012; 7: 4325-4333.
40. Mosesson M,. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-1904.
41. Kim J, Song H, Park I, Carlisle CR, Bonin K, Guthold M,. Denaturing of single electrospun fibrinogen fibers studied by deep ultraviolet fluorescence microscopy. Microsc Res Tech 2011; 74: 219-224.
42. Wang YP, Wei YL, Dong C,. Study on the interaction of 3, 3-bis (4-hydroxy-1-naphthyl)-phthalide with bovine serum albumin by fluorescence spectroscopy. J Photochem Photobiol A 2006; 177: 6-11.
43. Greenfield NJ,. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 2007; 1: 2876-2890.
44. Wang F, Huang W, Dai Z,. Spectroscopic investigation of the interaction between riboflavin and bovine serum albumin. J Mol Struct 2008; 875: 509-514.
45. Rybak-Smith MJ, Sim RB,. Complement activation by carbon nanotubes. Adv Drug Delivery Rev 2011; 63: 1031-1041.
46. Toda M, Arima Y, Iwata H,. Complement activation on degraded polyethylene glycol-covered surface. Acta Biomater 2010; 6: 2642-2649.
47. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E,. The role of nanoparticle size in hemocompatibility. Toxicology 2009; 258: 139-147.
48. Vauthier C, Persson B, Lindner P, Cabane B,. Protein adsorption and complement activation for di-block copolymer nanoparticles. Biomaterials 2011; 32: 1646-1656.
49. Hamad I, Hunter AC, Moghimi SM,. Complement monitoring of pluronic 127 gel and micelles: Suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100. J Control Release 2013; 170: 167-174.
50. Moghimi SM, Andersen AJ, Ahmadvand D, Wibroe PP, Andresen TL, Hunter AC,. Material properties in complement activation. Adv Drug Deliver Rev 2011; 63: 1000-1007.
51. Chowdhury SM, Kanakia S, Toussaint JD, Frame MD, Dewar AM, Shroyer KR, Moore W, Sitharaman B,. In vitro hematological and in vivo vasoactivity assessment of dextran functionalized graphene. Sci Rep 2013; 3: 2584.
52. Chapanian R, Constantinescu I, Brooks DE, Scott MD, Kizhakkedathu JN,. In vivo circulation, clearance, and biodistribution of polyglycerol grafted functional red blood cells. Biomaterials 2012; 33: 3047-3057.
53. Seong SY, Matzinger P,. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469-478.